Urothelial cell carcinoma

Showing 9 of 0 results

• Real-world safety of first-line therapies for locally advanced or metastatic urothelial cancer in the US

  ASCO GU

  • Publication summary
  • Publications
  • Urothelial cell carcinoma
• Retrospective, observational analysis of real-world safety outcomes in sacituzumab govitecan-treated patients with locally advanced/metastatic urothelial cancer

  ASCO GU

  • Publication summary
  • Publications
  • Urothelial cell carcinoma
• Uptake of maintenance immunotherapy and changes in upstream treatment selection among patients with urothelial cancer

  JAMA Network Open

  • Publication summary
  • Publications
  • Treatment patterns
  • Urothelial cell carcinoma
• Systemic anticancer therapy at the end of life—changes in usage pattern in the immunotherapy era

  JAMA Oncology

  • Real-world evidence
  • Publication summary
  • Publications
  • Treatment patterns
  • Urothelial cell carcinoma
  • Melanoma
  • Non-small cell lung cancer
• Real-world outcomes in locally advanced or metastatic urothelial carcinoma following platinum and PD-1/L1 inhibitor therapy

  Future Oncology

  • Publications
  • Comparative effectiveness
  • Urothelial cell carcinoma
• Real-world outcomes in patients with locally advanced or metastatic urothelial carcinoma receiving taxane monotherapy following platinum and anti-PD-1/L1 therapy

  ASCO GU Symposium

  • Publications
  • Unmet need
  • Urothelial cell carcinoma
• First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis

  Future Oncology

  • Publications
  • Treatment patterns
  • Urothelial cell carcinoma
• Effectiveness of first-line immune checkpoint blockade versus carboplatin-based chemotherapy for metastatic urothelial cancer

  European Urology

  • Publications
  • Comparative effectiveness
  • Urothelial cell carcinoma
• Using real-world cohorts to assess the generalizability and relevance of randomized clinical trials

  ASCO Annual Meeting

  • Publications
  • Health equity
  • Methodology
  • Multiple myeloma
  • Renal cell carcinoma
  • Urothelial cell carcinoma
  • Metastatic breast cancer
  • Non-small cell lung cancer